The Evaluation and Management of Coronary Artery Disease in the Lung Transplant Patient
Gregory Serrao, Manish Vinayak, Johny Nicolas, Varsha Subramaniam, Ashton C Lai, Daniel Laskey, Annapoorna Kini, Harish Seethamraju, Scott Scheinin, Pablo G Sanchez · 2023
Read The Evaluation and Management of Coronary Artery Disease in the Lung Transplant Patient by Gregory Serrao, Manish Vinayak, Johny Nicolas, Varsha Subramaniam, Ashton C Lai, Daniel Laskey, Annapoorna Kini, Harish Seethamraju, Scott Scheinin, Pablo G Sanchez (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10743826.txt.
Description
Serrao and co-authors wrote a review, published in 2023, on heart artery disease in people hoping for a lung transplant. A new lung can add years and quality of life in end-stage lung disease. The operation is high-risk, and the drugs that follow strain the body for years. Candidates must be otherwise healthy enough to survive both. Blocked heart arteries are one of the biggest factors in that judgment. The review covers how to assess and manage them in this setting.
The authors walk through the tests to find artery disease and judge its danger. They cover treatment options, from medicines to procedures that open or bypass blocked vessels. Timing matters: some fixes must come before listing for a transplant. The piece guides transplant teams through a common gate in selection. It aims to protect scarce donor lungs for those most likely to thrive with them.
Catalog record
| CREATOR | Gregory Serrao, Manish Vinayak, Johny Nicolas, Varsha Subramaniam, Ashton C Lai, Daniel Laskey, Annapoorna Kini, Harish Seethamraju, Scott Scheinin, Pablo G Sanchez |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |